Introduction In 2021, globally, cardiometabolic diseases (CMDs) accounted for 35% of the 1.73 billion disability-adjusted life years (DALYs) attributed to non-communicable diseases. The Healthy Life ...

Introduction Central lumbar spinal stenosis (LSS) is a common cause of pain, reduced function and quality of life in older adults. Current management of LSS includes surgery to decompress the spinal ...

Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...

Background The effects of fish oil (FO) in rheumatoid arthritis (RA) have not been examined in the context of contemporary treatment of early RA. This study examined the effects of high versus low ...

Bio-Gate: Update On The Hiprevision Clinical Trial For Hyprotecttm-Coated Hip Revision Implants. Study protocol published ...

Background The global proliferation of mobile phones offers opportunity for improved non-communicable disease (NCD) data collection by interviewing participants using interactive voice response (IVR) ...

Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.

Antenatal balanced energy-protein (BEP) dietary supplementation is a WHO recommendation in undernourished settings, but ...

Rationale Pulmonary rehabilitation (PR) is an effective, key standard treatment for people with COPD. Nevertheless, low participant uptake, insufficient attendance and high drop-out rates are reported ...

Background: Enthesitis is a recommended core domain for assessment of ankylosing spondylitis (AS), but no measurement has yet been validated according to Outcome Measures in Rheumatoid Arthritis ...

When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t just the sensation of pain — it was what that pain might represent.

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced ...